The rising prevalence in GLP-1 agonists for diabetes has sparked a debate about application forms : patches versus tablets . Traditionally , GLP-1 drugs were solely available in tablet form, but the https://robertadkw954773.blog2freedom.com/41055618/glp-1-skin-applications-vs-tablets-which-right-for-the-patient